维普中文期刊产品整合服务
15篇 您的检索式:作者名="PERENTESIS JP"
    题名 作者 年代 出处 被引量
1Children's Oncology Group's 2013 blueprint for research:acute myeloid leukemia显示文摘Gamis AS Alonzo TA Perentesis JP 0,,06:1
2Children's oncology group's 2013 blueprint for research:acute myeloid leukemia显示文摘Gamis AS Alonzo TA Perentesis JP 0,,06:1
3Autologous stem cell transplantation for high-risk Ewings sarcoma and other pediatric solid tumors显示文摘Fraser CJ Weigel BJ Perentesis JP 2006Bone Marrow Transplant2006,37,2:1
4Polymorphisms of drug metabolizing en- zymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications显示文摘Kelly KM Perentesis JP 2002Ann Oncol2002,13,1:1
5Genetic predisposition and treatment - related leukemia显示文摘Perentesis JP 2001Med Pediatr Oncol2001,36,5:1
6Protein toxin inhibitots of protein synthesis显示文摘Perentesis JP Miller SP Bodley JW 1992Biofactors1992,3,3:1
7Genetic predisposition and treatment-related leukemia显示文摘Perentesis JP 2001Med Pediatr Oncol2001,36,5:1
8Pilot study of intra- venous melphalan combined with continuous infusion L-S, R-buthi- onine sulfoximine for children with recurrent neuroblastoma显示文摘Anderson CP Matthay KK Perentesis JP 2015Ped- iatric Blood & Cancer2015,62,10:1
9Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia:a report from the children's oncology group显示文摘SHU XO PERENTESIS JP WEN W 2004Cancer Epidemiol Biomarkers Prev2004,13,:1
10Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study显示文摘Wagner LM Perentesis JP Reid JM Ames MM Safgren SL Nelson MD Jr 2010Pediatr Blood Cancer2010,54,4:1
11Children' s Oncology Group's 2013 blueprint for research: acute myeloid leuke- mia显示文摘Gamis AS Alonzo TA Perentesis JP 2013Pediatr Blood Cancer2013,60,6:1
12Genetic predisposition and treatmentrelated leukemia显示文摘Perentesis JP 2001Med Pediatr Oncol2001,36,5:1
13A phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed,refractory or secondary acute myeloid leukemia:a report from the Children's Oncology Group显示文摘Horton TM Perentesis JP Gamis AS 2014Pediatr Blood Cancer2014,61,:1
14Genetic predisposition and treatment -related leukemia显示文摘Perentesis JP 2001Med Pediatr Oncol2001,36,5:1
15Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia:A report from the Children's Oncology Group显示文摘Shu XO Perentesis JP Wen W 2004Cancer Epidemiol Biomarkers Prev2004,13,7:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费